New England Journal of Medicine· 2019Q1
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
- 4,783citations
- Q1SCImago
- 2019year
Short summary
Transcatheter aortic-valve replacement (TAVR) with a balloon-expandable valve was superior to surgery in low-risk patients with severe aortic stenosis, showing a significantly lower rate of death, stroke, or rehospitalization at 1 year (8.5% vs. 15.1%).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine